Analysts expect Alnylam Pharmaceuticals, Inc. to report revenue of 1.49 B for Q3 26, against a range of 1.35 B to 1.63 B. The most recent reported quarter, Q2 26, came in at 1.29 B, a 6.8% miss against the 1.38 B consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 500.92 M | 593.17 M | 594.19 M | 773.69 M | 1.25 B | 1.10 B | 1.17 B | 1.29 B | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 619.41 M | 593.45 M | 575.46 M | 709.49 M | 1.11 B | 1.23 B | 1.23 B | 1.47 B | 1.63 B | 1.79 B | 1.63 B | 1.81 B | 2.24 B | 2.46 B | 1.97 B | 1.85 B | ||||||||||
| Low Estimate | 511.47 M | 500.18 M | 535.64 M | 651.62 M | 914.97 M | 1.15 B | 1.14 B | 1.30 B | 1.35 B | 1.55 B | 1.40 B | 1.54 B | 2.06 B | 2.19 B | 1.68 B | 1.64 B | ||||||||||
| Consensus Estimate | 565.44 M | 546.82 M | 555.55 M | 680.56 M | 1.01 B | 1.19 B | 1.18 B | 1.38 B | 1.49 B | 1.67 B | 1.52 B | 1.67 B | 2.15 B | 2.33 B | 1.83 B | 1.75 B |
Analysts expect Alnylam Pharmaceuticals, Inc. to report earnings per share of 1.69 for Q3 26, against a range of 1.64 to 1.74. The most recent reported quarter, Q2 26, came in at 1.21, a 28.0% miss against the 1.68 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.87 | -0.65 | -0.44 | -0.51 | 1.84 | 0.82 | 1.51 | 1.21 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.89 | -0.59 | -0.85 | -0.47 | 0.58 | 1.28 | 0.92 | 1.77 | 1.74 | 2.47 | 2.24 | 2.75 | 3.29 | 3.37 | 2.59 | 3.03 | ||||||||||
| Low Estimate | -1.03 | -0.65 | -1.03 | -0.57 | 0.48 | 1.14 | 0.76 | 1.59 | 1.64 | 2.07 | 2.04 | 2.37 | 2.73 | 3.17 | 2.41 | 2.65 | ||||||||||
| Consensus Estimate | -0.96 | -0.62 | -0.94 | -0.52 | 0.53 | 1.21 | 0.84 | 1.68 | 1.69 | 2.27 | 2.14 | 2.56 | 3.01 | 3.27 | 2.50 | 2.84 |